Which brain supplements actually have evidence?
Caffeine has a small acute attention effect. Creatine remains uncertain for routine cognitive use, and several popular supplements have convincing null results.

Contents8 sections
- Evidence at a glance
- Creatine: separate plausibility from replicated benefit
- Fish oil and multivitamins: the headline can hide the outcome
- Where the negative evidence is useful
- How to read a supplement label after reading the studies
- Frequently asked questions
- Explore related pages
- How we reviewed the evidence
This review concerns brain performance and the outcomes named below. It is educational information, not medical advice. Helibrain sells none of the supplements or treatments rated here.
Evidence at a glance
How to read the table. The grade is our GRADE-style certainty in the stated outcome, using the existing Helibrain evidence base: High means strong confidence, Moderate means the conclusion is likely to hold, Low means it may change with better research, and Very low means it is very uncertain. A high grade can support little or no benefit. Grades apply to the named population, comparator and outcome, not to an ingredient or habit in every setting. [3]
Size and certainty are different. Hedges’ g, Cohen’s d and SMD express a difference in units of the variation between people. Around 0.2 is conventionally small, 0.5 moderate and 0.8 large; these are descriptions, not thresholds for a worthwhile personal benefit. A g of 0.2 does not mean 20% improvement. We preserve the source metric: a z-score difference, risk ratio (RR), odds ratio (OR) or hazard ratio (HR) is labelled separately. These measures cannot be ranked as though they were all the same. Intervals are 95% unless marked otherwise. Statistical intervals do not capture every source of bias. [4]
Scroll sideways to compare all study details.
| Intervention and outcome | Effect in plain words | Evidence grade | Number and type of studies | Who was tested | Studied dose or schedule | Harms and limits |
|---|---|---|---|---|---|---|
| Caffeine | Small acute attention-accuracy benefit: g = 0.27, 95% CI 0.17–0.37. [1] | High | 31 randomized double-blind trials overall; 16 for accuracy. | Rested healthy adults. | Studied single doses 40–400 mg; guidance ceiling 200 mg per dose. | Anxiety, jitteriness, disturbed sleep; count all sources. |
| Caffeine plus L-theanine versus placebo | Small attention-switching benefit: SMD = 0.33, 95% CI 0.13–0.54. [5] | Very low | 5 studies for this second-hour accuracy outcome. | Healthy adults. | Review median 89 mg caffeine plus 82 mg theanine. | Caffeine precautions still apply. |
| L-theanine added to caffeine | Extra benefit over caffeine alone is not established; no pooled additive estimate. [5] | Very low | Direct-comparison study count is not established in the review; no pooled additive estimate. | Healthy adults. | No established dose for an additional cognitive benefit. | A combination should not be assumed to prevent caffeine adverse effects. |
| Creatine: younger healthy people | Near-zero young-subgroup memory estimate: SMD = 0.02, 95% CI −0.27 to 0.31. Modest benefit or no benefit remain possible. [6] | Low | Corrected randomized-trial meta-analysis plus a preregistered crossover trial of 123 adults. | Younger healthy participants; the corrected subgroup included adolescents. | The crossover trial used 5 g/day for 6 weeks. | More reported side effects than placebo in that trial; consider kidney disease with a clinician. |
| Creatine: older adults | Large subgroup estimate, very uncertain: SMD = 0.80, 95% CI 0.25–1.34. [6] | Very low | Only 2 randomized trials, 57 participants in the corrected older subgroup. | Older adults; not proof of an age-specific treatment effect. | Trials used 20 g/day for 7 days or 5 g/day for 24 weeks. These are study protocols. | Small trials cannot establish uncommon harms or a preferred cognitive dose. |
| Omega-3: younger healthy people | No consistent cognitive improvement across the review; no single pooled effect for the whole cognitive battery. [7] | Low | Review of 24 randomized trials, with typically developing and clinical subgroups. | Adults and children; individual adult trials include low-intake samples. | DHA/EPA formulations and doses varied. | Fishy aftertaste and gastrointestinal symptoms. |
| Omega-3: older adults | Near-zero global-cognition estimate: g = 0.02, 95% CI −0.12 to 0.154. [8] | Moderate | Review of 25 randomized studies; individual cognitive outcomes use subsets. | Non-demented adults, mostly older; some studies included mild impairment. | About 1 g/day fish oil in VITAL; other trials used different formulations. | Gastrointestinal symptoms; more is not proven better for cognition. |
| Multivitamin-mineral | Very small global-cognition difference: 0.07 standardized units, 95% CI 0.03–0.11. [9] | Moderate | 2 global-cognition substudies within one parent randomized trial; not 2 independent trials. | US older adults; not evidence in healthy young adults. | One tested multivitamin-mineral tablet daily. | Do not stack overlapping products; formula-specific evidence is not a class guarantee. |
| B vitamins without deficiency | Little or no global-cognition difference: −0.01 z-score units, 95% CI −0.03 to 0.02. [10] | Moderate | Meta-analysis of 11 randomized trials, about 22,000 people. | Predominantly older adults, many with vascular risk. | Folate with or without B12/B6; formulations varied. | Excess B6 can cause neuropathy; deficiency treatment is a separate question. |
| Vitamin D in mostly replete older adults | Near-zero difference in annual cognitive change: 0.01 standardized units/year, 95% CI −0.01 to 0.02. [11] | High | 2 ancillary studies of the VITAL randomized trial, 4,218 participants. | Older adults, largely without deficiency. | Vitamin D3 2,000 IU/day. | This null finding does not apply to every medical reason for correcting deficiency. |
| Ginkgo: healthy-adult memory | Little or no effect: d = −0.04, 95% CI −0.17 to 0.07. [12] | High | 13 randomized memory studies, 1,132 participants. | Healthy adults. | Standardised extracts; doses varied. | Check interactions, especially anticoagulants; do not assume all extracts are equivalent. |
| Ginkgo: dementia prevention | No preventive benefit established: GEM hazard ratio 1.12, 95% CI 0.94–1.33. [13] | High | 2 large prevention trials: 3,069 and 2,854 participants. | Older adults, not young healthy users. | EGb 761, 120 mg twice daily in the prevention trials. | Medication interactions; the tested regimen is not a recommendation. |
| Cocoa flavanol extract | Little or no overall global-cognition effect: 0.03 z-score units, 95% CI −0.02 to 0.08 in COSMOS-Mind. [14] | High | One parent randomized trial with cognitive substudies; this estimate is from COSMOS-Mind. | Older US adults. | 500 mg cocoa flavanols/day. | A subgroup signal is not proof of benefit for everyone. |
| Bacopa monnieri | Some test-time improvements reported, but no trustworthy single g across outcomes; memory enhancement remains uncertain. [15] | Low | 9 randomized trials; 437 participants eligible for the meta-analysis. | Healthy adults, including older participants. | Typically 300–450 mg/day standardised extract for at least 12 weeks. | Gastrointestinal adverse effects; products and extracts differ. |
| Lion’s mane | No dependable pooled cognitive effect size; small positive studies do not establish a routine benefit. [16] [17] | Very low | 2 cited randomized studies: an MCI trial and a healthy-adult pilot; no pooled estimate. | Some people with mild impairment; some healthy younger adults. | Studied preparations commonly supplied 1.8–3 g/day. | Gastrointestinal symptoms; small samples leave safety uncertainty. |
Creatine: separate plausibility from replicated benefit
The original memory meta-analysis has a published correction in the authors’ reply. Its older-adult signal rests on a very small subgroup, whereas the larger preregistered healthy-adult trial found at most small, uncertain effects. EFSA’s evaluation did not establish the proposed cognitive health claim. [18] [6] [2] [19]
A newer broad meta-analysis reports positive findings on some outcomes. That is a reason for further study, not a reason to ignore different ages, tasks, trial quality or null outcomes. We do not extrapolate acute high-dose sleep-deprivation experiments into a daily dose for rested users. [20]
Fish oil and multivitamins: the headline can hide the outcome
Omega-3 results differ between global cognition, memory subtests and baseline dietary status. Cochrane’s prevention review and VITAL’s cognitive study are important checks on enthusiastic small-trial claims. An individual trial in low-DHA consumers was positive, while another healthy-adult trial was null. [21] [22] [23] [24]
The multivitamin signal is statistically convincing but small. COSMOS-Clinic, COSMOS-Mind and COSMOS-Web are linked substudies, not independent replications in unrelated trials. An earlier trial in male physicians did not show the same general cognitive benefit. Describing a score difference as years of younger brain age is a conversion, not evidence that ageing was reversed. [9] [14] [25] [26]
Where the negative evidence is useful
Ginkgo has been tested extensively enough that routine memory-enhancement and dementia-prevention claims should be treated sceptically. GEM’s cognitive follow-up and the separate GuidAge trial do not rescue those claims. A bleeding meta-analysis found no overall change in haemostatic measures, but that does not remove individual interaction precautions. [27] [28] [29]
B vitamins and vitamin D are not general cognition enhancers in adequately nourished older adults. Correcting a diagnosed deficiency is a different clinical question. The broader vitamin/mineral review supports keeping those claims separate. [10] [11] [30]
How to read a supplement label after reading the studies
A trial of one extract, dose and duration does not validate every bottle bearing the ingredient name. Bacopa’s systematic review and the healthy-young-adult lion’s mane pilot illustrate the limits of transferring a narrow study into a broad product promise. [31] [17]
For caffeine, healthy-adult ceilings are 200 mg per dose and 400 mg across a day; pregnancy has a lower limit. They are safety boundaries, not a prescription for focus. The sleep review gives a clear reason to count the cost of taking it late. [32] [33]
Frequently asked questions
What is the best brain supplement?
There is no supplement proven to broadly improve every cognitive ability. Caffeine has good evidence for a small acute attention effect; that is a much narrower claim.
Is creatine proven to improve memory?
Not as a routine intervention for all healthy adults. Older-adult results are based on small studies, and the larger preregistered healthy-adult trial found small, uncertain effects.
Should I take vitamins for brain health if I am not deficient?
The cognitive evidence does not support routine high-dose vitamin use. The small older-adult multivitamin result does not establish benefits in young adults or justify overlapping products.
Explore related pages
Explore long-term memory, read our diet review, try the n-back snapshot, and read what brain training can and cannot improve. The caffeine calculator helps count intake; it does not determine a safe personal dose.
These activities can help you observe or organise a task. Repeated scores are affected by practice and conditions; they are not a diagnosis or proof that an intervention improved your brain.
How we reviewed the evidence
We started with the Helibrain evidence base and research library, checked the original study or review behind each estimate, and compared supportive and contrary findings. The tables retain the existing outcome-specific grades. Some outcomes have only abstract-level access; access limits and study-quality concerns are recorded in the review notes. We do not treat lack of access alone as a reason to lower a grade. Sources below support different parts of the review and are not all independent studies. Last reviewed: 5 November 2026.
Sources
- Kasper Kløve et al. 2025. A systematic review and meta-analysis of the acute effect of caffeine on attention. DOI: 10.1007/s00213-025-06775-1
- Julia Fabienne Sandkühler et al. 2023. The effects of creatine supplementation on cognitive performance—a randomised controlled study. DOI: 10.1186/s12916-023-03146-5
- Nancy A. Santesso et al. 2019. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. DOI: 10.1016/j.jclinepi.2019.10.014
- Cohen. 2013. Statistical Power Analysis for the Behavioral Sciences. DOI: 10.4324/9780203771587
- Edward R. Payne et al. 2025. Effects of Tea (Camellia sinensis) or its Bioactive Compounds l -Theanine or l -Theanine plus Caffeine on Cognition, Sleep, and Mood in Healthy Participants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. DOI: 10.1093/nutrit/nuaf054
- Konstantinos Prokopidis et al. 2023. Author’s reply: Letter to the Editor: Double counting due to inadequate statistics leads to false-positive findings in “Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials”. DOI: 10.1093/nutrit/nuac111
- Ruth E Cooper et al. 2015. Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis. DOI: 10.1177/0269881115587958
- Anu Alex et al. 2019. Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis. DOI: 10.1093/nutrit/nuz073
- Chirag M. Vyas et al. 2024. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. DOI: 10.1016/j.ajcnut.2023.12.011
- Robert Clarke et al. 2014. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. DOI: 10.3945/ajcn.113.076349
- Jae Hee Kang et al. 2021. Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial. DOI: 10.1038/s41598-021-02485-8
- Keith R. Laws et al. 2012. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta‐analysis. DOI: 10.1002/hup.2259
- Steven Trent DeKosky. 2008. Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial. DOI: 10.1001/jama.2008.683
- Laura D. Baker et al. 2022. Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. DOI: 10.1002/alz.12767
- Chuenjid Kongkaew et al. 2013. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. DOI: 10.1016/j.jep.2013.11.008
- Koichiro Mori et al. 2008. Improving effects of the mushroom Yamabushitake ( Hericium erinaceus ) on mild cognitive impairment: a double‐blind placebo‐controlled clinical trial. DOI: 10.1002/ptr.2634
- Sarah Docherty et al. 2023. The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. DOI: 10.3390/nu15224842
- Konstantinos Prokopidis et al. 2022. Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. DOI: 10.1093/nutrit/nuac064
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) et al. 2024. Creatine and improvement in cognitive function: Evaluation of a health claim pursuant to article 13(5) of regulation (EC) No 1924/2006. DOI: 10.2903/j.efsa.2024.9100
- Xu Chen et al. 2024. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. DOI: 10.3389/fnut.2024.1424972
- Emma Sydenham et al. 2012. Omega 3 fatty acid for the prevention of cognitive decline and dementia. DOI: 10.1002/14651858.cd005379.pub3
- Jae Hee Kang et al. 2022. Marine n‐3 fatty acids and cognitive change among older adults in the VITAL randomized trial. DOI: 10.1002/trc2.12288
- Welma Stonehouse et al. 2013. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. DOI: 10.3945/ajcn.112.053371
- Philippa A. Jackson et al. 2011. No effect of 12 weeks' supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18–35 years. DOI: 10.1017/s000711451100403x
- Lok‐Kin Yeung et al. 2023. Multivitamin Supplementation Improves Memory in Older Adults: A Randomized Clinical Trial. DOI: 10.1016/j.ajcnut.2023.05.011
- Francine Grodstein et al. 2013. Long-Term Multivitamin Supplementation and Cognitive Function in Men. DOI: 10.7326/0003-4819-159-12-201312170-00006
- Beth Ellen Snitz. 2009. Ginkgo biloba for Preventing Cognitive Decline in Older Adults A Randomized Trial. DOI: 10.1001/jama.2009.1913
- Bruno J. Vellas et al. 2012. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. DOI: 10.1016/s1474-4422(12)70206-5
- Andrea J. Kellermann et al. 2011. Is There a Risk of Bleeding Associated with Standardized Ginkgo biloba Extract Therapy? A Systematic Review and Meta‐analysis. DOI: 10.1592/phco.31.5.490
- Anne WS Rutjes et al. 2018. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life. DOI: 10.1002/14651858.cd011906.pub2
- Matthew Paul Pase et al. 2012. The Cognitive-Enhancing Effects of Bacopa monnieri : A Systematic Review of Randomized, Controlled Human Clinical Trials. DOI: 10.1089/acm.2011.0367
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). 2015. Scientific Opinion on the safety of caffeine. DOI: 10.2903/j.efsa.2015.4102
- Carissa Gardiner et al. 2023. The effect of caffeine on subsequent sleep: A systematic review and meta-analysis. DOI: 10.1016/j.smrv.2023.101764